Elixir Medical's Lithix HC-IVL system data demonstrates effectiveness in clinical trial

Elixir Medical has announced positive six-month data from the PINNACLE I study evaluating its LithiX Hertz Contact (HC) IVL for the treatment of moderate to severely calcified coronary artery lesions demonstrating safety and efficacy.